Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmaLogic Appoints Etienne Montagut as President and CEO | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

PharmaLogic Appoints Etienne Montagut as President and CEO

Montagut brings more than 25 years of senior leadership experience in the pharmaceutical sector.

PharmaLogic Holdings Corp., a CDMO specialized in radiopharmaceuticals, has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective June 1, 2025.

Mr. Montagut brings more than 25 years of senior leadership experience in the pharmaceutical sector, with a track record of driving growth and executing strategic transformation across global markets. Prior to joining PharmaLogic one year ago, he held executive positions at Lantheus, GE HealthCare and Ipsen.

Steve Chilinski, who has led the company through 13 years of exceptional growth, retired as Chief Executive Officer on June 1, and will assume the role of Executive Chairman of the Board.

“I’m grateful to Steve and the Board for their trust and their confidence in PharmaLogic’s future,” said Etienne Montagut. “The company has experienced great success, and I’m very excited about our next chapter. PharmaLogic has talent, culture, technology, and resources to lead the future of radiopharmaceuticals and improve global patient access to novel diagnostics and therapies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics